UBS ASSET MANAGEMENT AMERICAS LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1. A total of 42 filers reported holding PDL BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2017$37,195,560,000
-1.3%
37,300,000
-1.3%
0.03%
-5.9%
Q3 2017$37,702,476,000
+1.8%
37,800,000
+1.6%
0.03%
-5.6%
Q2 2017$37,026,388,000
+4.7%
37,200,000
+4.2%
0.04%0.0%
Q1 2017$35,357,851,000
+101511.8%
35,700,0000.0%0.04%
-7.7%
Q4 2016$34,797,000
+0.2%
35,700,0000.0%0.04%
+5.4%
Q3 2016$34,718,000
+2.8%
35,700,0000.0%0.04%
-2.6%
Q2 2016$33,759,000
-1.9%
35,700,000
-6.3%
0.04%
-5.0%
Q1 2016$34,429,000
+10.9%
38,100,000
-3.7%
0.04%
+14.3%
Q4 2015$31,053,000
-18.7%
39,550,000
-9.4%
0.04%
-16.7%
Q3 2015$38,200,000
-7.5%
43,650,0000.0%0.04%
+5.0%
Q2 2015$41,292,000
-0.5%
43,650,000
+0.2%
0.04%0.0%
Q1 2015$41,512,000
+2.7%
43,550,000
+3.8%
0.04%
+5.3%
Q4 2014$40,439,000
+3.9%
41,950,000
+5.0%
0.04%
-2.6%
Q3 2014$38,916,000
-6.8%
39,950,000
+8.1%
0.04%
-7.1%
Q2 2014$41,738,000
+3.9%
36,950,000
-2.8%
0.04%
-2.3%
Q1 2014$40,187,00038,000,0000.04%
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2015
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 19,703,000$19,738,0002.83%
ASCEND CAPITAL, LLC 43,840,000$43,727,0001.65%
ZAZOVE ASSOCIATES LLC 2,080,000$2,085,0000.11%
Verition Fund Management LLC 1,000,000$1,004,0000.08%
OAKTREE CAPITAL MANAGEMENT LP 4,940,000$4,940,0000.07%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 3,420,000$3,424,0000.05%
UBS ASSET MANAGEMENT AMERICAS LLC 37,800,000$37,702,476,0000.03%
Sterneck Capital Management, LLC 18,000$18,0000.01%
ADVENT CAPITAL MANAGEMENT /DE/ 235,000$212,0000.00%
INVESTMENT CENTERS OF AMERICA INC 50,000$50,0000.00%
View complete list of PDL BIOPHARMA INC shareholders